This site is intended for healthcare professionals only

Access our Learning Management System Now

Therapy with non-vitamin K oral anticoagulants (NOACs) gives us with the best opportunity that we have had to increase anticoagulation for patient with at-risk atrial fibrillation and greatly reduce stroke burden that complicates this arrhythmia.

Professor John Camm, NOAC Faculty member